Is a low Triglyceride to HDL ratio good?

A low triglyceride to HDL ratio (below 2.0) is excellent for health, indicating good insulin sensitivity and lower cardiovascular disease risk. The ideal ratio is under 1.0, achieved through healthy diet, regular exercise, and weight management.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the Triglyceride to HDL Ratio

The triglyceride to HDL cholesterol ratio is one of the most powerful predictors of cardiovascular health and metabolic function. This simple calculation provides valuable insights into your risk for heart disease, insulin resistance, and metabolic syndrome. Unlike traditional cholesterol tests that focus solely on LDL levels, this ratio offers a more comprehensive view of your cardiovascular risk profile.

To calculate your ratio, simply divide your triglyceride level by your HDL cholesterol level. For example, if your triglycerides are 100 mg/dL and your HDL is 50 mg/dL, your ratio would be 2.0. This number carries significant implications for your health, as research consistently shows that lower ratios correlate with better cardiovascular outcomes and improved metabolic health.

Why a Low Ratio Is Beneficial

A low triglyceride to HDL ratio is indeed good for your health. This favorable ratio indicates that your body efficiently processes fats and maintains healthy cholesterol balance. When your ratio is low, it suggests that you have lower levels of harmful triglycerides circulating in your blood and higher levels of protective HDL cholesterol, creating an optimal environment for cardiovascular health.

Cardiovascular Protection

Research published in major cardiovascular journals demonstrates that individuals with lower triglyceride to HDL ratios have significantly reduced risk of heart attacks, strokes, and other cardiovascular events. The protective effect stems from HDL's role in removing excess cholesterol from arteries while lower triglycerides reduce the formation of dangerous small, dense LDL particles that contribute to arterial plaque buildup.

Insulin Sensitivity Marker

The triglyceride to HDL ratio serves as an excellent surrogate marker for insulin resistance. Studies show that ratios above 3.0 often indicate insulin resistance, while ratios below 2.0 suggest good insulin sensitivity. This connection makes the ratio particularly valuable for identifying metabolic dysfunction before it progresses to prediabetes or type 2 diabetes.

If you're concerned about your metabolic health and want to understand your insulin sensitivity through comprehensive biomarker testing, regular monitoring can provide crucial insights into your risk factors.

Optimal Ratio Ranges

Understanding what constitutes a healthy triglyceride to HDL ratio helps you set appropriate health goals. The medical community has established clear guidelines for interpreting these ratios, though optimal targets may vary slightly based on individual risk factors and overall health status.

For most adults, aiming for a ratio below 2.0 provides significant health benefits. However, achieving a ratio below 1.0 represents optimal metabolic health and minimal cardiovascular risk. These targets apply to both men and women, though women typically have higher HDL levels, which often results in more favorable ratios.

Gender Differences

Women generally maintain higher HDL cholesterol levels than men, particularly before menopause. This biological advantage often translates to better triglyceride to HDL ratios. However, hormonal changes during menopause can affect both triglyceride and HDL levels, making regular monitoring especially important for women over 50.

Health Implications of Different Ratios

Your triglyceride to HDL ratio provides insights into multiple aspects of your health beyond cardiovascular risk. A low ratio typically indicates efficient fat metabolism, balanced blood sugar levels, and reduced inflammation throughout your body. Conversely, elevated ratios signal metabolic dysfunction that can affect numerous organ systems.

Metabolic Syndrome Risk

Individuals with triglyceride to HDL ratios above 3.5 face significantly increased risk of metabolic syndrome, a cluster of conditions including high blood pressure, elevated blood sugar, excess abdominal fat, and abnormal cholesterol levels. This syndrome dramatically increases the likelihood of developing type 2 diabetes, heart disease, and stroke.

Inflammation and Oxidative Stress

High triglyceride to HDL ratios correlate with increased systemic inflammation and oxidative stress. These conditions damage blood vessels, accelerate aging, and contribute to chronic disease development. By maintaining a low ratio, you help protect your body from these harmful processes.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Factors That Influence Your Ratio

Multiple lifestyle and genetic factors affect your triglyceride to HDL ratio. Understanding these influences empowers you to make targeted improvements to your cardiovascular health. While genetics play a role, lifestyle modifications can significantly impact your ratio, often producing noticeable improvements within weeks to months.

  • Diet composition, particularly refined carbohydrate and sugar intake
  • Physical activity levels and exercise intensity
  • Body weight and fat distribution
  • Alcohol consumption patterns
  • Smoking status
  • Sleep quality and duration
  • Stress levels and management techniques
  • Certain medications, including beta-blockers and diuretics
  • Underlying conditions like diabetes, hypothyroidism, or kidney disease

For comprehensive cardiovascular health monitoring that includes triglyceride and HDL testing along with advanced markers, regular biomarker assessment provides the data you need to track your progress and optimize your health strategies.

Strategies to Improve Your Ratio

Improving your triglyceride to HDL ratio requires a multifaceted approach targeting both components of the equation. The most effective strategies simultaneously lower triglycerides while raising HDL cholesterol, creating a synergistic effect that rapidly improves your ratio.

Dietary Modifications

Your diet profoundly impacts both triglycerides and HDL levels. Reducing refined carbohydrates and added sugars can lower triglycerides by 20-50% within weeks. Focus on whole foods, including fatty fish rich in omega-3s, nuts, seeds, and olive oil. These foods not only reduce triglycerides but also boost HDL production.

  • Limit added sugars to less than 25 grams daily
  • Choose complex carbohydrates over refined options
  • Include fatty fish like salmon or sardines twice weekly
  • Add nuts and seeds to meals and snacks
  • Use olive oil as your primary cooking fat
  • Increase soluble fiber intake through oats, beans, and vegetables

Exercise and Physical Activity

Regular physical activity powerfully improves your triglyceride to HDL ratio through multiple mechanisms. Aerobic exercise reduces triglyceride production in the liver while stimulating enzymes that help clear triglycerides from your bloodstream. Additionally, both aerobic and resistance training increase HDL cholesterol levels.

Aim for at least 150 minutes of moderate-intensity aerobic activity weekly, combined with two or more resistance training sessions. High-intensity interval training (HIIT) shows particular promise for improving lipid profiles, with studies demonstrating significant ratio improvements after just 8-12 weeks of regular HIIT sessions.

Monitoring and Testing Your Levels

Regular monitoring of your triglyceride and HDL levels provides essential feedback on your cardiovascular health and the effectiveness of your lifestyle interventions. Most healthcare providers recommend annual lipid panels for healthy adults, but more frequent testing may benefit those actively working to improve their ratios or managing cardiovascular risk factors.

Standard lipid panels measure total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. From these values, you can easily calculate your triglyceride to HDL ratio. For the most accurate results, fast for 9-12 hours before testing, as recent meals significantly affect triglyceride levels.

Advanced lipid testing provides additional insights beyond standard panels. These tests measure particle sizes and numbers, offering more precise cardiovascular risk assessment. Small, dense LDL particles and high triglyceride levels often occur together, making comprehensive testing valuable for understanding your complete lipid profile.

When to Seek Medical Guidance

While lifestyle modifications effectively improve most triglyceride to HDL ratios, certain situations warrant medical consultation. If your ratio exceeds 4.0 despite lifestyle changes, or if you have additional cardiovascular risk factors, working with a healthcare provider ensures comprehensive risk management.

Medical evaluation becomes particularly important if you experience symptoms suggesting cardiovascular disease, such as chest pain, shortness of breath, or unusual fatigue. Additionally, family history of early heart disease or genetic lipid disorders may require specialized management beyond lifestyle interventions.

Some individuals may benefit from medications to optimize their lipid profiles. Statins primarily lower LDL cholesterol but can modestly improve triglyceride to HDL ratios. Fibrates specifically target high triglycerides, while niacin can raise HDL levels, though its use has declined due to side effects. Your healthcare provider can determine whether medication complements your lifestyle efforts.

The Bottom Line on Low Triglyceride to HDL Ratios

A low triglyceride to HDL ratio is unequivocally beneficial for your health, serving as a powerful indicator of cardiovascular wellness and metabolic function. This simple calculation provides valuable insights that guide your health optimization efforts and help prevent chronic disease development.

By maintaining a ratio below 2.0, and ideally below 1.0, you significantly reduce your risk of heart disease, diabetes, and metabolic syndrome. The strategies to achieve these optimal ratios align with overall healthy living principles: balanced nutrition, regular physical activity, stress management, and adequate sleep.

Remember that improving your triglyceride to HDL ratio is a journey, not a destination. Small, consistent changes in your daily habits can produce significant improvements over time. Regular monitoring helps you track progress and adjust your approach as needed, empowering you to take control of your cardiovascular health and overall wellbeing.

References

  1. McLaughlin, T., Reaven, G., Abbasi, F., et al. (2005). Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? American Journal of Cardiology, 96(3), 399-404.[PubMed][DOI]
  2. Gaziano, J. M., Hennekens, C. H., O'Donnell, C. J., Breslow, J. L., & Buring, J. E. (1997). Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation, 96(8), 2520-2525.[PubMed][DOI]
  3. Salazar, M. R., Carbajal, H. A., Espeche, W. G., et al. (2012). Relation among the plasma triglyceride/high-density lipoprotein cholesterol ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. American Journal of Cardiology, 109(12), 1749-1753.[PubMed][DOI]
  4. Vega, G. L., Barlow, C. E., Grundy, S. M., Leonard, D., & DeFina, L. F. (2014). Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. Journal of Investigative Medicine, 62(2), 345-349.[PubMed][DOI]
  5. Pacifico, L., Bonci, E., Andreoli, G., et al. (2014). Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutrition, Metabolism and Cardiovascular Diseases, 24(7), 737-743.[PubMed][DOI]
  6. Kelley, G. A., Kelley, K. S., Roberts, S., & Haskell, W. (2012). Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Clinical Nutrition, 31(2), 156-167.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my triglyceride to HDL ratio at home?

You can test your triglyceride to HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes both triglyceride and HDL cholesterol testing. The program provides comprehensive cardiovascular biomarker analysis with personalized insights delivered through their app.

What is the ideal triglyceride to HDL ratio?

The ideal triglyceride to HDL ratio is below 1.0, which indicates excellent metabolic health and minimal cardiovascular risk. A ratio below 2.0 is considered good, while ratios above 3.0 suggest increased risk for insulin resistance and heart disease.

How quickly can I improve my triglyceride to HDL ratio?

You can see improvements in your triglyceride to HDL ratio within 4-8 weeks through dietary changes and exercise. Reducing sugar and refined carbohydrates while increasing physical activity typically shows the fastest results, with some people experiencing 20-30% improvements in their ratio within this timeframe.

Does fasting affect the triglyceride to HDL ratio calculation?

Yes, fasting significantly affects triglyceride levels, which can change your ratio calculation. For accurate results, you should fast for 9-12 hours before testing. HDL levels remain relatively stable, but triglycerides can increase 20-30% after meals, potentially skewing your ratio.

Can medications improve my triglyceride to HDL ratio?

Yes, certain medications can improve your ratio. Fibrates like fenofibrate specifically lower triglycerides by 20-50%. Statins modestly improve ratios by lowering triglycerides 10-30% and raising HDL 5-10%. However, lifestyle changes often produce similar or better improvements without side effects.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details